Total Return chart Lunit Inc.

Stocks

End-of-day quote Korea S.E. 2026-10-30			5-day change	1st Jan Change
15,690.00 ^KRW	+4.74%		+38.85%	-23.65%

10-23	Summit Therapeutics Inc. And Lunit Inc. Announce Agreement To Apply AI-Powered SCOPE IO Platform For Tumor Microenvironment Analysis In Immuno-Oncology Development	CI
10-14	Lunit Announces Nature Medicine Study Findings on Lunit Scope Identifying Her2 Expression Differences Linked to Treatment Response	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.